课题基金 / 基金详情

Elucidation of molecular mechanisms of osteoclastogenesis for developing drugs that inhibit bone resorption

Elucidation of molecular mechanisms of osteoclastogenesis for developing drugs that inhibit bone resorption
阐明破骨细胞生成的分子机制,用于开发抑制骨吸收的药物
批准号:
18390409
负责人:
INOUE Jun-ichiro
金额:
$11.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

INOUE Jun-ichiro的其他基金

相似基金

相关文献

中文摘要
翻译
TRAF6对于破骨细胞的形成至关重要,并且在破骨细胞祖细胞中RANK-和cd40介导的IKK和MAPKs的激活中起着至关重要的作用。尽管在破骨细胞形成过程中需要IKK和MAPKs的激活,但RANK而不是CD40能够促进破骨细胞的形成,因为只有RANK能够诱导长期激活由免疫球蛋白样受体/含itam的接头复合物介导的共刺激信号,而这些信号是诱导NFATcl(破骨细胞形成的主要基因)所必需的。我们之前的数据表明,RANK而不是CD40拥有一个独特的结构域,该结构域与traf6结合位点协同作用,以可持续的方式激活共刺激信号并促进破骨细胞的发生。我们发现了这样一个功能性的蛋白质结构域,HCR,它在各种脊椎动物的rank中高度保守,对于长期激活共刺激信号至关重要。将HCR添加到CD40的细胞质尾部,使CD40能够诱导共刺激信号的持续激活和随后的NFATcl的激活。此外,HCR在刺激下显著增强了HCR-窝藏受体的内化。这些结果表明,HCR可以通过控制受体的膜运输,将RANK-TRAF6轴连续连接到持续的共刺激信号通路,并且HCR可能是病理性骨吸收的新治疗靶点。
英文摘要
TRAF6 is essential for osteoclastogenesis and plays a crucial role in both RANK- and CD40-mediated activation of IKK and MAPKs in osteoclast progenitor cells. Despite the requirement for IKK and MAPKs activation in osteoclastogenesis, RANK, but not CD40, can promote osteoclastogenesis because only RANK can induce long-term activation of the co-stimulatory signals mediated by immunoglobulin-like receptors/ITAM-containing adaptors complexes, which are required for induction of NFATcl, a master gene in osteoclastogenesis. Our previous data suggested that RANK, but not CD40, harbors a unique domain that functions in concert with the TRAF6-binding site to activate the co-stimulatory signals in a sustainable way and promote osteoclastogenesis. We identify such a functional protein domain, HCR, that is highly conserved in RANKs from various vertebrates and is essential for long-term activation of co-stimulatory signals. Addition of the HCR to the cytoplasmic tail of CD40 renders CD40 capable of inducing sustained activation of co-stimulatory signals and subsequent activation of NFATcl. Furthermore, the HCR dramatically enhances internalization of HCR-harboring receptors upon stimulation. These results suggest that the HCR can continuously link the RANK-TRAF6 axis to sustained co-stimulatory signaling pathways through control of the membrane trafficking of receptors and that the HCR may be a novel therapeutic target for pathological bone resorption.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms and physiological roles of the TRAF signal-mediated NF-kB activation
TRAF信号介导的NF-kB激活的分子机制和生理作用
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Qin, J., Gohda J, Maezawa Y, Sharma RK, Ito H, Yamamoto T, Maezawa Y, Sharma RK, Ito H, Yamamoto T, Maezawa Y, Sharma RK, Ito H, Yamamoto T, 井上純一郎, Jun-ichiro Inoue]
通讯作者: Jun-ichiro Inoue
Phospho-proteomics analysis of EGFR signal cascades in a non-small cell cancer cell line expressing mutated EGFR
表达突变 EGFR 的非小细胞癌细胞系中 EGFR 信号级联的磷酸化蛋白质组学分析
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [松村隆之, 井上純一郎, 茂木秀彦, 山崎孔輔, 山口憲孝, 尾山大明, 宮坂隆]
通讯作者: 宮坂隆
Characterization of breast cancer cells with constitutively activated NFkB
具有组成型激活的 NFkB 的乳腺癌细胞的表征
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [山口憲孝, 仙波憲太郎, 井上純一郎]
通讯作者: 井上純一郎
DOI: 10.1111/j.1349-7006.2008.00746.x
发表时间: 2008-04-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Miyasaka, Takashi, Morita, Masahiro, Yamamoto, Tadashi]
通讯作者: Yamamoto, Tadashi
43
    Advanced Animal Model Support
    • 批准号:
      16H06276
    • 项目类别:
      Grant-in-Aid for Scientific Research on Innovative Areas ― Platforms for Advanced Technologies and Research Resources
    • 资助金额:
      $1538.53万
    • 财政年份:
      2016
    • 负责人:
      INOUE Jun-ichiro
    • 依托单位:
    Committee on Promoting Collaboration in Life Sciences
    • 批准号:
      16H06297
    • 项目类别:
      Grant-in-Aid for Scientific Research on Innovative Areas ― Platforms for Advanced Technologies and Research Resources
    • 资助金额:
      $149.76万
    • 财政年份:
      2016
    • 负责人:
      INOUE Jun-ichiro
    • 依托单位:
    Molecular mechanisms of abnormal differentiation and transcriptional regulation in cancer cel
    • 批准号:
      17014017
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $32.13万
    • 财政年份:
      2005
    • 负责人:
      INOUE Jun-ichiro
    • 依托单位:
    Elucidation of molecular mechanisms of osteoclastogenesis and its application for bone disease therapy
    • 批准号:
      16390428
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2004
    • 负责人:
      INOUE Jun-ichiro
    • 依托单位:
    海外基金